Analyst firms · Guggenheim · NUVL

Guggenheim NUVL price target and rating history

Nuvalent Inc. (NUVL) · Health Care

Guggenheim rates Nuvalent Inc. (NUVL) Buy with a $122 price target, as of its latest action on Sep 4, 2025. It has published 3 rating actions on NUVL since July 2023, including 0 upgrades and 0 downgrades.

Current rating
Buy
Price target
$122
Median target, all firms
Too few
Actions on NUVL
3

Guggenheim price target on NUVL

$122$89$56202420252026
Guggenheim price target on NUVL, each point a stated target, July 2023 to September 2025.

Every Guggenheim rating on NUVL

How other firms rate NUVL

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
BernsteinMkt Perform$124Jun 24, 2026
Wells FargoOverweight$116Mar 30, 2026
Truist SecuritiesBuyNov 24, 2025

Questions about Guggenheim and NUVL

What is Guggenheim's price target for NUVL?
Guggenheim's latest stated price target for Nuvalent Inc. (NUVL) is $122, from its action on Sep 4, 2025.
What is Guggenheim's rating on NUVL?
Guggenheim rates NUVL Buy, a bullish rating, as of Sep 4, 2025.
When did Guggenheim last change its view on NUVL?
On Sep 4, 2025, Guggenheim resumes coverage at Buy, price target $122.

All Guggenheim ratingsNUVL news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.